<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7C777568-AEA8-464E-8AF8-B1DFE6358842"><gtr:id>7C777568-AEA8-464E-8AF8-B1DFE6358842</gtr:id><gtr:name>Bar-Ilan University</gtr:name><gtr:address><gtr:line1>Bar-Ilan University</gtr:line1><gtr:line4>Ramat-Gan</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/51B3600A-54C2-4F6B-99AE-03CD7220EBBA"><gtr:id>51B3600A-54C2-4F6B-99AE-03CD7220EBBA</gtr:id><gtr:name>Royal College of Surgeons in Ireland</gtr:name><gtr:address><gtr:line1>Academic Centre</gtr:line1><gtr:line2>Coombe Women's Hospital</gtr:line2><gtr:line3>Dublin 8</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C777568-AEA8-464E-8AF8-B1DFE6358842"><gtr:id>7C777568-AEA8-464E-8AF8-B1DFE6358842</gtr:id><gtr:name>Bar-Ilan University</gtr:name><gtr:address><gtr:line1>Bar-Ilan University</gtr:line1><gtr:line4>Ramat-Gan</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/51B3600A-54C2-4F6B-99AE-03CD7220EBBA"><gtr:id>51B3600A-54C2-4F6B-99AE-03CD7220EBBA</gtr:id><gtr:name>Royal College of Surgeons in Ireland</gtr:name><gtr:address><gtr:line1>Academic Centre</gtr:line1><gtr:line2>Coombe Women's Hospital</gtr:line2><gtr:line3>Dublin 8</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4DE6B156-67AA-449A-B9C6-7CA922BB9E6D"><gtr:id>4DE6B156-67AA-449A-B9C6-7CA922BB9E6D</gtr:id><gtr:firstName>Samuel</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>McConkey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081962"><gtr:id>FB45A81C-DC13-466B-917B-3E7BD29E0344</gtr:id><gtr:title>Triple Therapy Trial</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081962</gtr:grantReference><gtr:abstractText>A great deal has been learned about the way HIV-1 behaves in an infected person from studies of how much virus can be found in the blood over time after the start of effective drug therapy with several antiviral drugs. Much less is known about the second strain of HIV, HIV-2, which is largely found in West Africa and is associated with a lower rate of progression to disease. In this study we will compare what happens to the amount of virus in the blood between people infected with HIV-1 or HIV-2 or both viruses when they start anti-HIV drug therapy.</gtr:abstractText><gtr:technicalSummary>This is a clinical research study with the aim of comparing the viral dynamics in patients with HIV-1, HIV-2 and dual HIV-1/2 infection when these patients start combination anti-retroviral therapy (ART). Patients eligible for ART will be recruited from the GUM clinic in Fajara and admitted to the adult ward for intensive monitoring of their plasma viral load before and after the initiation of therapy and subsequently followed with further blood samples as an outpatient. The intention is to recruit 20 patients from each group into the study. The principal laboratory study will be on the viral load decay over time after therapy starts, but the virus-specific immune response will also be studied.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>95772</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bar-Ilan University</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>The Mina and Everard Goodman Faculty of Life Sciences</gtr:department><gtr:description>Mathematical modelling analysis A Neumann</gtr:description><gtr:id>B4ED43BE-FE4D-4293-BB18-570C811A18BD</gtr:id><gtr:impact>Poster presented at HIV dynamics conference, and paper in preparation</gtr:impact><gtr:outcomeId>CmHZntPprTK-1</gtr:outcomeId><gtr:partnerContribution>The helped to analyse the numberical data.</gtr:partnerContribution><gtr:piContribution>WE designed the study, organised the study, collected the data, wrote up the material, and presented it.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bar-Ilan University</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>The Mina and Everard Goodman Faculty of Life Sciences</gtr:department><gtr:description>Modelling HIV-2 viral dynamics on treatment</gtr:description><gtr:id>B2408DF3-8D02-41B2-B6D3-074509296CDC</gtr:id><gtr:impact>presentation of a poster at an international meeting on retrovirus dynamics</gtr:impact><gtr:outcomeId>QMFxhfUYt9e-1</gtr:outcomeId><gtr:partnerContribution>analysis of HIV-2 viral dynamics
presentation of a poster at a retroviral dynamics meeting</gtr:partnerContribution><gtr:piContribution>Design study, recruit patients,</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Global Studies Sussex</gtr:department><gtr:description>IDS</gtr:description><gtr:id>2997BBEF-0842-472A-A897-2897244D449D</gtr:id><gtr:impact>PhD thesis, and award
3 book chapters
better understanding of Gambia and MRC</gtr:impact><gtr:outcomeId>QiiSbfNrwue-1</gtr:outcomeId><gtr:partnerContribution>A joint MRC/ESRC PhD studentship was proposed, saught, and successfully won, which led to a successful PhD award. The student was jointly supervised by myself and by a co-supervisor at U of Sussex. 
Ths has led to 3 book chapters, as well as the thesis.</gtr:partnerContribution><gtr:piContribution>co-suppervision of student</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal College of Surgeons in Ireland</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Department of International Health and Tropical Medicine</gtr:department><gtr:description>RCSI</gtr:description><gtr:id>45B6494C-34A2-46C1-9C4D-5DA037C8845C</gtr:id><gtr:impact>Hosted a 2h workshop at American Society of Tropical Medicine and Hygiene in Washington DC in 2010, 
Late-breaker abstract for ASTMH meeting in Philadelphia 2011
paper in preparation</gtr:impact><gtr:outcomeId>frEPbGZkvZ9-1</gtr:outcomeId><gtr:partnerContribution>Estabilshed a National Malaria Surveillance system in Gambia, and evaluated it.</gtr:partnerContribution><gtr:piContribution>designed and executed the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Drafted national HIV treatment guidelines and Global Fund application</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>AEF13E19-9A73-46CE-8B8A-EB8DAF8C94BC</gtr:id><gtr:impact>The experiences of treatment of HIV-2 and HIV-1 in MRC Gambia laid the basis for the development of hte national programme there. I drafted most of the treatment section for the national programme and wrote the grant proposal which was successful a obtaining funding from Global Fund for Gambia to set up HIs treatment. This led to widespread treatment availability for HIV in Gambia.</gtr:impact><gtr:outcomeId>ckqBWJgiEPe</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>PCR based measure of HIV-2 viral load. 
This assay was improved, made more robuse, and standardise as part of this project , with also funds from EDCTP, a personal fellowship for Dr Abraham Alabi.</gtr:description><gtr:id>59BFCEAC-3172-4C36-9A8E-588139243BDF</gtr:id><gtr:impact>better HIV-2 viral load assay</gtr:impact><gtr:outcomeId>UfUmZ8qyoag</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HIV-2 quantitative viral load assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>12C5C0C3-3984-4FB3-A102-9494475D0658</gtr:id><gtr:title>Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4312437420f8d76a925048cdb000f56"><gtr:id>e4312437420f8d76a925048cdb000f56</gtr:id><gtr:otherNames>Mendy ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>pm_16605_15_18508941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37BDA7EB-12CA-4367-AF4C-3845493FD6C4</gtr:id><gtr:title>Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16605_15_16709858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>107460EE-C64A-4AC9-A99E-230FABAC43A6</gtr:id><gtr:title>Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf15dad4439b15c78ef2845f4adcd3"><gtr:id>7ecf15dad4439b15c78ef2845f4adcd3</gtr:id><gtr:otherNames>Jallow S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>pm_16605_15_17329450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89CE2C88-695F-47F3-BEA6-649427A2A36F</gtr:id><gtr:title>Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1d435a89e140a383feb0876fd6dbe9e"><gtr:id>a1d435a89e140a383feb0876fd6dbe9e</gtr:id><gtr:otherNames>Martinez-Steele E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_16605_15_17255738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFFE46E5-A046-492D-8ED8-F4EA74CC065F</gtr:id><gtr:title>Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf15dad4439b15c78ef2845f4adcd3"><gtr:id>7ecf15dad4439b15c78ef2845f4adcd3</gtr:id><gtr:otherNames>Jallow S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_16605_15_16791023</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081962</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>